IOSP

Innospec Inc. Materials - Specialty Chemicals Investor Relations →

YES
14.2% BELOW
↓ Approaching Was -10.2% last week
-15% -10% -5% 0% 5% 10% 15%+
Buy Threshold $96.37
14-Week RSI 70
Rel. Volume (14w) This week's trading vs. the 14-week average 1.1x
Buyers vs. Sellers (14w) Are up-weeks or down-weeks getting more volume? 0.89

Innospec Inc. (IOSP) closed at $82.73 as of 2026-06-19, trading 14.2% below its 200-week moving average of $96.37. This places IOSP in the extreme value zone. The stock is currently moving closer to the line, down from -10.2% last week. The 14-week RSI sits at 70, indicating neutral momentum.

Trading volume is running at 1.1x of its 14-week average, which is in the normal range. The balance between buying and selling volume (0.89 ratio) is neutral — neither side is clearly dominating.

Over the past 1418 weeks of data, IOSP has crossed below its 200-week moving average 14 times. On average, these episodes lasted 26 weeks. Historically, investors who bought IOSP at the start of these episodes saw an average one-year return of +31.2%.

With a market cap of $2.0 billion, IOSP is a mid-cap stock. The company generates a free cash flow yield of 0.6%. Return on equity stands at 8.7%. The stock trades at 1.5x book value.

Over the past 27.2 years, a hypothetical investment of $100 in IOSP would have grown to $1584, compared to $902 for the S&P 500. That represents an annualized return of 10.7% vs 8.4% for the index — confirming IOSP as a market-beating investment and the kind of quality company where buying during 200-week moving average touches has historically been rewarded.

Free cash flow has been volatile over the past several years, making the quality of earnings harder to assess.

Business Health

Annual financials — how the underlying business has performed over the past several years.

Cash Flow Free cash flow & net income ($M)

Revenue Annual revenue ($M) — business growth proxy

Total Debt Balance sheet debt ($M)

ROIC Return on invested capital (%)

FCF Yield Free cash flow / market cap (%) — Yartseva signal

Gross Margin Pricing power & competitive moat (%)

Shares Outstanding Buybacks vs dilution (millions)

Growth of $100: IOSP vs S&P 500

Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.

What Happens After IOSP Crosses Below the Line?

Across 14 historical episodes, buying IOSP when it crossed below its 200-week moving average produced an average return of +25.7% after 12 months (median +37.0%), compared to +16.7% for the S&P 500 over the same periods. 71% of those episodes were profitable after one year. After 24 months, the average return was +44.4% vs +21.9% for the index.

Each line shows $100 invested at the moment IOSP crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.

Bean Score Experimental

The Bean Score measures how far a stock's free cash flow yield has deviated from its own quarterly baseline, normalized by the stock's historical behavior. Between earnings dates, FCF is constant — so the score is purely a function of stock price. The levels below show at what prices IOSP would reach each dislocation threshold.

Current Bean Score -0.83σ
Current FCF Yield 2.70%
Baseline Yield 2.99%
Historical σ 0.24pp

Dislocation Price Levels

Prices where IOSP's Bean Score would hit each σ threshold. Valid until next earnings report: 2026-08-04.

LevelσPriceSignal
Deep Value+2σ$64.75Unusually cheap — potential buy zone
Value+1σ$69.61Cheap vs. own history
Fair Value+0σ$75.26Historical mean behavior
Expensive-1σ$81.91Expensive vs. own history
Deep Expensive-2σ$89.85Unusually expensive — potential trim zone

Quarterly FCF & Yield Trailing twelve-month free cash flow and yield at each quarter end

Data depth: 2 quarterly baselines, 22 price observations — Limited history (4+ quarters preferred for reliability)

Signal Accuracy Collecting Data

The Bean Score system is accumulating weekly data to validate signal accuracy. After 13+ weeks of history, this section will display win rates and average returns for each σ threshold crossing — answering the question: "When this score says cheap or expensive, does the price subsequently move in the expected direction?"

11 / 13 weeks minimum

Theoretical framework — not backtested or forward-tested. The Bean Score uses trailing twelve-month free cash flow yield as a dislocation identifier. It measures whether the market has pushed a stock's yield unusually far from its own baseline behavior. These levels are reference points for identifying potential swing trade opportunities, not buy/sell signals. FCF values update quarterly with earnings; between reports, all movement is price-driven.

Dislocation Scores Experimental

Each score measures deviation from IOSP's own historical baseline — the same idea as the Bean Score, applied to different fundamentals. Positive means cheaper or more dislocated than this stock's norm. Scores marked σ are normalized by the stock's own variability; pp values are simple deltas from its recent baseline.

Yield Dislocation +2.40σ Dividend yield vs own 10-yr norm
Drawdown Score +0.98σ Distance from line vs own history
Sector-Relative N/A Vs sector median this week
Buyback Acceleration -0.7pp YoY share change vs own 3-yr pace (− = accelerating)
Insider Intensity 18th TTM buys / market cap, percentile of buyers
FCF Yield vs History -2.9pp Vs own recent annual mean
Earnings Quality Stable Accrual gap trend (+2.9pp of revenue)

Theoretical framework — not backtested. These scores describe how unusual today's readings are for this specific company. They are starting points for research, not buy or sell signals. Annual-statement scores (buyback, accruals, FCF vs history) rest on only ~4 yearly data points and are deltas, not sigmas.

Advertisement

Historical Touches

IOSP has crossed below its 200-week MA 14 times with an average 1-year return of +31.2% after recovery.

Crossed BelowRecoveredWeeksMax Depth1-Year ReturnReturn Since Touch
Apr 1999Jan 20019041.0%-33.8%+1415.9%
Mar 2001May 200189.7%+58.2%+1811.2%
Jan 2003Feb 200329.4%+67.6%+1457.5%
Mar 2003Mar 200318.5%+102.6%+1549.3%
Apr 2003Aug 20031712.4%+120.3%+1425.3%
Feb 2005Feb 200521.8%+5.4%+1047.9%
Mar 2005Jan 20064624.0%+27.2%+1065.5%
Jan 2008Jan 200816.1%-61.8%+666.1%
Aug 2008Oct 201011380.9%-23.8%+571.0%
Mar 2020May 20201014.3%+52.9%+30.5%
Jun 2020Jun 202013.2%+35.4%+28.8%
Sep 2020Nov 2020914.3%+34.7%+34.9%
Sep 2022Oct 202221.7%+20.8%+3.1%
Mar 2025Ongoing68+33.0%Ongoing-15.0%
Average26+31.2%

Frequently Asked Questions

Is IOSP below its 200-week moving average?

Yes. As of 2026-06-19, Innospec Inc. (IOSP) is trading 14.2% below its 200-week moving average of $96.37. The current price is $82.73.

What is IOSP's 200-week moving average price?

Innospec Inc.'s 200-week moving average is $96.37 as of 2026-06-19. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.

What happens when IOSP drops below its 200-week moving average?

IOSP has crossed below its 200-week moving average 14 times in our data. On average, buying at that moment produced a one-year return of +31.2%. These dips have historically been decent entry points. These episodes lasted 26 weeks on average.

Is IOSP a good value right now?

Here's what our data says about IOSP as of 2026-06-19: The stock is below its 200-week moving average, which is the starting point for our analysis. The 14-week RSI is 70. Free cash flow yield is 0.6%. Return on equity is 8.7%. Price-to-book is 1.5x. This is not a buy or sell recommendation — always do your own research.

How does IOSP compare to the S&P 500?

Over the past 27.2 years, $100 invested in IOSP would have grown to $1584, compared to $902 for the S&P 500. That's 10.7% annualized vs 8.4% for the index. IOSP has outperformed the broader market over this period.

Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.

Data as of week of 2026-06-19